Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Nordgård, Oddmund ^a   Singh, Gurpartap ^a   Solberg, Steinar ^b   Jørgensen, Lars ^b   Halvorsen, Ann Rita ^c   Smaaland, Rune ^a   Brustugun, Odd Terje ^a,c   Helland, Åslaug ^a,c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MOLECULAR MARKER;

AGED; ARTICLE; BLOOD; CEACAM5 GENE; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DSG3 GENE; EPCAM GENE; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KRT19 GENE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SURGERY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SFTPB GENE; SFTPC GENE; TUMOR BIOPSY;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; EXPRESSED SEQUENCE TAGS; FEMALE; GENE EXPRESSION; GPI-LINKED PROTEINS; HUMANS; KERATIN-19; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; TUMOR MARKERS, BIOLOGICAL;

EID: 84877020914     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062153     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 127: 2893-2917.
2. Edge S, Byrd D, Compton C, Fritz A, Greene F, et al. (2010) AJCC Cancer Staging Manual. New York: Springer, 7th edition.
3. Cancer Registry of Norway (2012) Cancer in Norway 2010- Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway.
4. Effenberger KE, Sienel W, Pantel K, (2007) Lymph node micrometastases in lung cancer. Cancer Treat Res 135: 167-175.
5. Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, et al. (2012) Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 30: 525-532.
6. Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, et al. (2011) Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 29: 1556-1563.
7. Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, et al. (2012) Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18: 2391-2401.
8. Saintigny P, Coulon S, Kambouchner M, Ricci S, Martinot E, et al. (2005) Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma. Int J Cancer 115: 777-782.
9. Xi L, Coello MC, Litle VR, Raja S, Gooding WE, et al. (2006) A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res 12: 2484-2491.
10. Benlloch S, Galbis-Caravajal JM, Alenda C, Peiro FM, Sanchez-Ronco M, et al. (2009) Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases. Ann Oncol 20: 91-97.
11. Qiu Y, Yang H, Chen H, Ge L, Xu X, et al. (2010) Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis. Jpn J Clin Oncol 40: 146-152.
12. Lardinois D, Leyn PD, Schil PV, Porta RR, Waller D, et al. (2006) ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 30: 787-792.
13. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
14. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
15. Jolliffe IT (2002) Principal Component Analysis. Springer.
16. Venables WN, Ripley BD (2002) Modern Applied Statistics with S. Springer.
17. Xi L, Gooding W, McCarty K, Godfrey TE, Hughes SJ, (2006) Identification of mRNA markers for molecular staging of lymph nodes in colorectal cancer. Clin Chem 52: 520-523.
18. Heinrich S, Hartl D, Griese M, (2006) Surfactant protein A-from genes to human lung diseases. Curr Med Chem 13: 3239-3252.
19. Perez-Gil J, Weaver TE, (2010) Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda) 25: 132-141.
20. Ohlsson L, Hammarstrom ML, Israelsson A, Naslund L, Oberg A, et al. (2006) Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR. Br J Cancer 95: 218-225.
21. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, et al. (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148: 349-361.
22. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, et al. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339: 580-584.
23. Bednarz-Knoll N, Alix-Panabières C, Pantel K, (2011) Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 13: 228.
24. Tjensvoll K, Nordgard O, Smaaland R (2013) Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications. Int J Cancer: In press.
25. Nordgard O, Oltedal S, Kørner H, Aasprong OG, Tjensvoll K, et al. (2009) Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Ann Surg 249: 602-607.
26. Nordgård O, Oltedal S, Aasprong OG, Søreide JA, Søreide K, et al. (2012) Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients. Ann Surg Oncol 19: 3719-3726.
27. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K, (1999) Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 17: 19-24.
28. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, et al. (2012) Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13: 688-695.
29. Rusch VW, Hawes D, Decker PA, Martin SE, Abati A, et al. (2011) Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol 29: 4313-4319.